Site US10063 — Quincy, Massachusetts

Site US10063 is a clinical research site located in Quincy, Massachusetts, United States 02169.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Site US10063 has participated in 1 clinical trials.

Therapeutic areas: Painful Diabetic Peripheral Neuropathy (PDPN).

Sponsors: Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US10063?

Site US10063 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US10063 conducted?

Site US10063 has 1 clinical trials on record. Their work covers Painful Diabetic Peripheral Neuropathy (PDPN).

Is Site US10063 accredited by Crixeo Health?

Site US10063 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US10063?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.